UCSF

Topics and Expertise: QBI

UCSF School of Pharmacy leads in NIH funding for the 42nd straight year

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Map of protein systems reveals new targets for cancer treatment

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

How cells multitask: the magic of molecular switches

Research unearths new details about the protein networks that keep cells healthy

Cancer drug stops SARS-CoV-2 in the lab

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

QBI probes three lethal coronaviruses to find possible drug targets

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

QBI Coronavirus Research Group races toward a cure

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

Pages